Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $255 | $118 | $116 | $255 |
| Gross Profit | -$255 | -$118 | -$116 | -$255 |
| % Margin | – | – | – | – |
| R&D Expenses | $94 | $118 | $106 | $99 |
| G&A Expenses | $318 | $428 | $425 | $426 |
| SG&A Expenses | $318 | $428 | $425 | $426 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $412 | $546 | $531 | $525 |
| Operating Income | -$412 | -$546 | -$531 | -$525 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $78 | $0 | $0 | $0 |
| Pre-Tax Income | -$334 | -$545 | -$531 | -$525 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$255 | -$545 | -$530 | -$525 |
| % Margin | – | – | – | – |
| EPS | -0.038 | -0.082 | -0.08 | -0.089 |
| % Growth | 53.2% | -2.4% | 10.2% | – |
| EPS Diluted | -0.038 | -0.082 | -0.08 | -0.089 |
| Weighted Avg Shares Out | 6,655 | 6,655 | 6,632 | 5,890 |
| Weighted Avg Shares Out Dil | 6,655 | 6,655 | 6,632 | 5,890 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $255 | $255 | $255 | $255 |
| EBITDA | -$157 | -$290 | -$276 | -$270 |
| % Margin | – | – | – | – |